Blisibimod

Names

[ CAS No. ]:
1236126-45-6

[ Name ]:
Blisibimod

Biological Activity

[Description]:

Blisibimod (A 623) is a potent and selective tetravalent inhibitor of B-cell activating factor (BAFF). Blisibimod can be used for the research of systemic lupus erythematosus (SLE)[1][2].

[Related Catalog]:

Research Areas >> Inflammation/Immunology

[In Vitro]

Blisibimod 以高亲和力阻断所有三种形式的 BAFF[1]。

[References]

[1]. Merrill JT, et, al. Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018 Jun;77(6):883-889.  

[2]. Lenert A, wt, al. Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Des Devel Ther. 2017 Mar 13;11:747-757.  

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.